Drug Development
Arsenic trioxide inhibits hepatitis C virus replication
Published in Hepatitis Weekly, October 4th, 2004
According to a study from Taiwan, "hepatitis C virus (HCV) is a serious global problem, and present therapeutics are inadequate to cure HCV infection. In the present study, various antiviral assays show that arsenic trioxide (As2 O3 ) at submicromolar concentrations is capable of inhibiting HCV replication."
"The 50% effective concentration (EC50 ) of As2 O3 required to inhibit HCV replication was 0.35 mcM when it was determined by a reporter-based HCV replication assay, and the EC50 was below 0.2 mcM when it was determined by...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2004-10-04)
More Articles from Hepatitis Weekly
- Antiviral Therapy
Multiferon is an alternative for treating difficult chronic hepatitis C cases - Diagnostics
Specific patient circumstances should be considered prior to liver biopsy - Drug Addiction
Substance abuse programs would slow HCV transmissions among homeless men - Foodborne Disease
Uncooked deer meat consumption presents a risk for hepatitis E virus infection - Adverse Drug Effects
Sevoflurane exposure is associated with a case of infant hepatitis - Business Update
VScan exposure increases in the Caribbean - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
